Background: A simple predictive indicator of mortality and morbidities is essential to assess neonatal illness severity and plan proper management. Objective: This study aimed to test the time-dependent performance of the Clinical Risk Index for Babies (CRIB) II in predicting mortality and major short-term morbidities among very low birth weight infants (VLBWIs). Methods: This population-based prospective study from 67 Korean Neonatal Network centers performed between 2013 and 2016 included 5,296 VLBWIs with CRIB II calculation and 6,398 infants with CRIB II calculation but without the base excess (CRIB II-BE). A regression model predicting time-dependent mortality and morbidities using the CRIB II score was designed. The discriminate ability of the CRIB II and CRIB II-BE scores in predicting mortality and morbidities was explored using receiver-operating characteristic analysis. Results: CRIB II performed significantly better in predicting mortality than did gestational age or birth weight alone. The time-dependent performance of CRIB II was good in the first 30 days (area under the curve [AUC], 0.8435) and at 31–90 days (AUC, 0.8458). However, it was poor after 90 days (AUC, 0.6576). Specific CRIB II cutoffs were associated with severe intraventricular hemorrhage (AUC, 0.81), bronchopulmonary dysplasia (AUC, 0.77), and mortality or major morbidities (AUC, 0.80), respectively. The model using CRIB II-BE showed similar performance in predicting mortality and morbidities to that of the CRIB II model. Conclusion: Certain CRIB II cutoffs were significantly associated with time-dependent mortality, particularly within the first 90 days after birth as well as with short-term morbidities.

1.
Parry
G
,
Tucker
J
,
Tarnow-Mordi
W
;
UK Neonatal Staffing Study Collaborative Group
.
CRIB II: an update of the clinical risk index for babies score
.
Lancet
.
2003
May
;
361
(
9371
):
1789
91
.
[PubMed]
0140-6736
2.
Gooden
M
,
Younger
N
,
Trotman
H
.
What is the best predictor of mortality in a very low birth weight infant population with a high mortality rate in a medical setting with limited resources?
Am J Perinatol
.
2014
Jun
;
31
(
6
):
441
6
.
[PubMed]
0735-1631
3.
Greenwood
S
,
Abdel-Latif
ME
,
Bajuk
B
,
Lui
K
;
NSW and ACT Neonatal Intensive Care Units Audit Group
.
Can the early condition at admission of a high-risk infant aid in the prediction of mortality and poor neurodevelopmental outcome? A population study in Australia
.
J Paediatr Child Health
.
2012
Jul
;
48
(
7
):
588
95
.
[PubMed]
1034-4810
4.
Guenther
K
,
Vach
W
,
Kachel
W
,
Bruder
I
,
Hentschel
R
.
Auditing neonatal intensive care: is prem a good alternative to crib for mortality risk adjustment in premature infants?
Neonatology
.
2015
;
108
(
3
):
172
8
.
[PubMed]
1661-7800
5.
Gagliardi
L
,
Cavazza
A
,
Brunelli
A
,
Battaglioli
M
,
Merazzi
D
,
Tandoi
F
, et al.
Assessing mortality risk in very low birthweight infants: a comparison of CRIB, CRIB-II, and SNAPPE-II
.
Arch Dis Child Fetal Neonatal Ed
.
2004
Sep
;
89
(
5
):
F419
22
.
[PubMed]
1359-2998
6.
Reid
S
,
Bajuk
B
,
Lui
K
,
Sullivan
EA
;
NSW and ACT Neonatal Intensive Care Units Audit Group, PSN
.
Comparing CRIB-II and SNAPPE-II as mortality predictors for very preterm infants
.
J Paediatr Child Health
.
2015
May
;
51
(
5
):
524
8
.
[PubMed]
1034-4810
7.
Groenendaal
F
,
de Vos
MC
,
Derks
JB
,
Mulder
EJ
.
Improved SNAPPE-II and CRIB II scores over a 15-year period
.
J Perinatol
.
2017
May
;
37
(
5
):
547
51
.
[PubMed]
0743-8346
8.
Lodha
A
,
Sauvé
R
,
Chen
S
,
Tang
S
,
Christianson
H
.
Clinical Risk Index for Babies score for the prediction of neurodevelopmental outcomes at 3 years of age in infants of very low birthweight
.
Dev Med Child Neurol
.
2009
Nov
;
51
(
11
):
895
900
.
[PubMed]
0012-1622
9.
Seaton
SE
,
Barker
L
,
Draper
ES
,
Abrams
KR
,
Modi
N
,
Manktelow
BN
.
Estimating neonatal length of stay for babies born very preterm
.
Arch Dis Child Fetal Neonatal Ed
.
2018
Mar
.
[PubMed]
1359-2998
10.
Papile
LA
,
Burstein
J
,
Burstein
R
,
Koffler
H
.
Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm
.
J Pediatr
.
1978
Apr
;
92
(
4
):
529
34
.
[PubMed]
0022-3476
11.
Bell
MJ
,
Ternberg
JL
,
Feigin
RD
,
Keating
JP
,
Marshall
R
,
Barton
L
, et al.
Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging
.
Ann Surg
.
1978
Jan
;
187
(
1
):
1
7
.
[PubMed]
0003-4932
12.
Ehrenkranz
RA
,
Walsh
MC
,
Vohr
BR
,
Jobe
AH
,
Wright
LL
,
Fanaroff
AA
, et al.;
National Institutes of Child Health and Human Development Neonatal Research Network
.
Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia
.
Pediatrics
.
2005
Dec
;
116
(
6
):
1353
60
.
[PubMed]
0031-4005
13.
Richardson
DK
,
Corcoran
JD
,
Escobar
GJ
,
Lee
SK
.
SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores
.
J Pediatr
.
2001
Jan
;
138
(
1
):
92
100
.
[PubMed]
0022-3476
14.
HOSMER DW
.
LEMESHOW S. Applied Logistic Regression
. 2nd ed.
New York
:
John Wiley & Sons, Inc.
;
2000
.
15.
Badi
NH
.
Asymptomatic Distribution of Goodness-ofFit Tests in Logistic Regression Model
.
Open J Stat
.
2017
;
7
(
03
):
434
45
. 2161-718X
16.
Dorling
JS
,
Field
DJ
,
Manktelow
B
.
Neonatal disease severity scoring systems
.
Arch Dis Child Fetal Neonatal Ed
.
2005
Jan
;
90
(
1
):
F11
6
.
[PubMed]
1359-2998
17.
Patrick
SW
,
Schumacher
RE
,
Davis
MM
.
Methods of mortality risk adjustment in the NICU: a 20-year review
.
Pediatrics
.
2013
Mar
;
131
Suppl 1
:
S68
74
.
[PubMed]
0031-4005
18.
Medlock
S
,
Ravelli
AC
,
Tamminga
P
,
Mol
BW
,
Abu-Hanna
A
.
Prediction of mortality in very premature infants: a systematic review of prediction models
.
PLoS One
.
2011
;
6
(
9
):
e23441
.
[PubMed]
1932-6203
19.
Horbar
JD
,
Onstad
L
,
Wright
E
.
Predicting mortality risk for infants weighing 501 to 1500 grams at birth: a National Institutes of Health Neonatal Research Network report
.
Crit Care Med
.
1993
Jan
;
21
(
1
):
12
8
.
[PubMed]
0090-3493
20.
Ezz-Eldin
ZM
,
Hamid
TA
,
Youssef
MR
,
Nabil
HD
.
Clinical risk index for babies (crib ii) scoring system in prediction of mortality in premature babies
.
J Clin Diagn Res
.
2015
Jun
;
9
(
6
):
SC08
11
.
[PubMed]
2249-782X
21.
Draper
ES
,
Manktelow
BN
,
Cuttini
M
,
Maier
RF
,
Fenton
AC
,
Van Reempts
P
, et al.;
EPICE Cohort
.
Variability in very preterm stillbirth and in-hospital mortality across Europe
.
Pediatrics
.
2017
Apr
;
139
(
4
):
e20161990
.
[PubMed]
0031-4005
22.
Park
JH
,
Chang
YS
,
Sung
S
,
Ahn
SY
,
Park
WS
.
Trends in overall mortality, and timing and cause of death among extremely preterm infants near the limit of viability. PLoS One. 2017;12(1):e0170240. 23Chien LY, Whyte R, Thiessen P, Walker R, Brabyn D, Lee SK. Snap-ii predicts severe intraventricular hemorrhage and chronic lung disease in the neonatal intensive care unit
.
J Perinatol
.
2002
Jan
;
24
(
1
):
26
30
.
[PubMed]
0743-8346
23.
Lee
SK
,
Aziz
K
,
Dunn
M
,
Clarke
M
,
Kovacs
L
,
Ojah
C
, et al.;
Canadian Neonatal Network
.
Transport Risk Index of Physiologic Stability, version II (TRIPS-II): a simple and practical neonatal illness severity score
.
Am J Perinatol
.
2013
May
;
30
(
5
):
395
400
.
[PubMed]
1098-8785
24.
Beltempo
M
,
Shah
PS
,
Ye
XY
,
Afifi
J
,
Lee
S
,
McMillan
DD
;
Canadian Neonatal Network Investigators
.
SNAP-II for prediction of mortality and morbidity in extremely preterm infants
.
J Matern Fetal Neonatal Med
.
2018
Mar
;
•••
:
1
8
.
[PubMed]
1476-7058
25.
Chang
YS
,
Park
HY
,
Park
WS
.
The korean neonatal network: an overview
.
J Korean Med Sci
.
2015
Oct
;
30
Suppl 1
:
S3
11
.
[PubMed]
1011-8934
26.
Choi
CW
,
Park
MS
.
Data management and site-visit monitoring of the multi-center registry in the korean neonatal network
.
J Korean Med Sci
.
2015
Oct
;
30
Suppl 1
:
S19
24
.
[PubMed]
1011-8934
27.
Choi CW, Park MS. Data management and site-visit monitoring of the multi-center registry in the korean neonatal network. J Korean Med Sci. 2015 Oct;30 Suppl 1:S19–24.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.